Atlas Trials

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Clinical trial NCT07405086 · RECRUITING

Trial details

NCT number
NCT07405086
Sponsor
OHSU Knight Cancer Institute
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular CarcinomaAdvanced Lung Non-Small Cell CarcinomaAdvanced Malignant Solid NeoplasmAdvanced MelanomaAdvanced Renal Cell CarcinomaMetastatic Biliary Tract CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaMetastatic Hepatocellular CarcinomaMetastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Solid Neoplasm
Start date
2026-06-08
Primary completion
2028-12-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.